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Abstract Hypertension, a key risk factor for stroke,
cardiovascular disease and dementia, is associated
with chronic vascular inflammation, and although
poorly understood, putative mechanisms include pro-
inflammatory responses induced by mechanical
stretching, with cytokine release and associated up-
regulated expression of adhesion molecules. Because
blood pressure increases with age, we measured
baseline and tumour necrosis alpha (TNF-α)-stimulated
CD11b/CD18 adhesion molecule expression on leuco-
cytes to assess any association between the two. In 38
subjects (mean age 85 years), consecutively enrolled
from Belfast Elderly Longitudinal Free-Living Aging
Study (BELFAST), baseline and TNF-α-stimulated
CD11b/CD18 expression on separated monocytes and
neutrophils increased with systolic blood pressure
>120 mmHg (p=0.05) and for lymphocytes, with
diastolic blood pressure >80 mmHg (p<0.05).These
findings show increased potential stickiness of intra-
vascular cells with increasing blood pressure which is
accentuated by TNF-α, and suggest mechanistic
reasons why better hypertension control is important.
Keywords Blood pressure . TNF-α . Leucocyte
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Introduction
The prevalence of hypertension—a major risk factor
for stroke, cardiovascular disease and dementia—
increases with age. It reduces healthy life expectancy
in ageing populations by contributing in a major way
to disability (Hajjar et al. 2007). One of the earliest
manifestations of hypertension and associated athero-
sclerosis includes endothelial dysfunction in the vascu-
lar tree (Krieglstein and Granger 2001). Although the
mechanism of its action is not well understood, it has
been suggested that hypertension can damage vascu-
lar endothelial cells by a combination of shear stress
secondary to flow or mechanical stretching related to
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increased pulse pressure (Katsumi et al. 2004; Cheng
et al. 1996). Changes in adaption induced by
disturbed versus laminar flow are therefore key
events. Endothelial cells respond to damage, stress
or mechanical stretch by up-regulation of cytokines or
chemokines mediated through NF-κΒ, which initiate
an inflammatory response in an attempt to delimit
damage (Riou et al. 2007; Orr et al. 2005; Dorffel et
al. 1999; Albelda et al. 1994).
The integrin family of molecules are αβ hetero-
dimers which are important in cell–matrix and cell–
cell adhesion functions. They have a common β
subgroup (CD18) and one of three possible α
subunits (CD11a, CD11b and CD11c). CD11b/CD18
plays an important role in the early recruitment and
migration of leucocytes into an inflamed area and is
up-regulated on neutrophils and monocytes by ligands
such as ICAM-1 on the ‘damaged’ endothelial cells.
The CD11b/CD18/ICAM-1 ligand interaction between
leucocytes and endothelium encourages neutrophils to
stop, adhere and roll along the endothelium, and
monocytes are facilitated to adhere and diapedese
between endothelial cells and the extracellular space.
Both contribute to the inflammatory response by further
up-regulation of chemokine and cytokine mediators
within the extracellular space.
Blood pressure increases with age and is present in
approximately two thirds of people over the age of 65
(Joint National Committee on Prevention, Detection,
Evaluation and Treatment of High Blood Pressure
1997). Furthermore the JNC VII guidelines suggested
a category of blood pressure in the ‘prehypertension’
range associated with increased cardiovascular risk
(Chobanian et al. 2003). This has been confirmed by a
number of large studies (Lewington et al. 2002;
Prospective Studies Collaboration 1995) and most
recently by Lawes et al. (2008) who showed excess
risk beginning with a systolic blood pressure as low
as 115 mmHg, with 54% of stroke and 46% of
ischaemic heart disease events occurring in persons
with blood pressure in this range.
In this study we measured CD11b/CD18 adhesion
molecule expression on leucocytes in very elderly
subjects because activated granulocytes and mono-
cytes express large amounts of CD11b/CD18 com-
pared to the other CD11a/CD18 and CD11c/CD18
integrins. Furthermore, CD11b/CD18 is mainly
contained within a large pool of intracellular granules
in neutrophils and is up-regulated very manyfold (6 to
8×105), by a whole range of inflammatory mediators
including cytokines, which is not the case for the
other integrins (Mazzone and Ricevuti 1995). We
argued that since blood pressure increases with age,
there might be evidence of an associated pro-
inflammatory response. The cytokine TNF-α, central
to the immune response, up-regulates β2 integrin
expression in acute and chronic inflammatory clinical
situations, and we have investigated its effect on
CD11b expression in an ‘in vitro’ situation, in an
attempt to model what may happen clinically.
Here we describe up-regulation of CD11b/CD18
adhesion molecule on leucocytes in older subjects with
increasing systolic blood pressure and find that this up-
regulation is accentuated by the cytokine TNF-α.
Subjects, methods and materials
Subjects
Subjects were a randomly recruited but consecutive
group of 38 elderly subjects, enlisted as part of a
longitudinal study of ageing—Belfast Elderly Longi-
tudinal Free-Living Aging Study (BELFAST); (Rea et
al. 1997, 2009). This study was parallel to but part of
the ongoing main BELFAST study. Elderly subjects
were recruited with the criteria of the Senieur protocol
(Ligthart et al. 1984) and within the time constraint of
a master’s research project on age-related change in
CD11b/CD18 integrin expression (Armstrong et al.
2001). The Senieur protocol, developed in the frame-
work EURAGE (Concerted Action Programme on
Ageing in the European Community) established
exacting admission criteria for human immunogeronto-
logical studies, based on clinical and laboratory infor-
mation (Ligthart et al. 1984). Subjects enlisted into the
BELFAST study were community living, apparently
well, independently mobile, mentally competent by
Folstein mental assessment (28/30) and able to give
written consent (Folstein et al. 1991). Throughout the
BELFAST study, general practitioners in Greater
Belfast (population approximately 500,000) were
invited to enlist nonagenarian, octogenarian and
70-year-old subjects, known to them, who approached
‘Senieur’ or ‘elite’ status. Of those willing to
volunteer, less than one in four elderly subjects met
the criteria. Ethical permission for the study was
obtained from the Queens University of Belfast.
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Materials and methods
Blood pressure Blood pressure measurements were
made in the morning in the subject’s home, using a
conventional mercury sphygmomanometer and after a
10-min rest, during which the research nurse took a
brief medical and drug history from the subject.
Classical Korotkoff 1 (systolic) and 5 (diastolic)
phases were used to define blood pressure.
Basal expression of CD11b/CD18 on neutrophils,
monocytes and lymphocytes Whole blood (10 ml),
collected into endotoxin-free tubes containing 25 IU of
preservative-free heparin/ml (CP Pharmaceuticals Ltd.,
Wrexham, UK), was used for flow cytometry analysis of
CD11b/CD18 adhesion molecule up-regulation within
2 h of venipuncture. CD11b/CD18 expression on
nonstimulated leucocytes was analysed using standard
methods—20 μl of phycoerythrin-conjugated monoclo-
nal CD11b antibody (anti-CD11b; Becton Dickinson,
San Jose, CA) were added to 100 μl of whole blood.
Appropriate controls for nonspecific binding were
prepared for each subject. Labelled samples were
analysed using FACScan flow cytometry (Becton
Dickinson), calibrated using Calibrite beads and the
Lysys11software program for acquisition and analysis.
Neutrophil and lymphocyte cell populations were
identified by combining light-scattering properties with
appropriate fluorescent marking (FITC-conjugated
monoclonal anti-CD14). A minimum of 104 cells was
analysed per sample and the cellular fluorescence
quantified as median channel fluorescence (MCF).
In vitro stimulation of leucocytes using TNF-α Whole
blood incubated for 1 h at 37°C with human
recombinant TNF-α (National Institute for Biological
Standards and Controls, Potters Bar, UK) was diluted
with PBS to low (10 IU) and high (100 IU)
concentration. Cells were labelled with anti-CD11b
and evaluated as described previously (Armstrong
et al. 2001). Whole blood, incubated for 1 h at 37°C,
without prior addition of TNF-α served as a negative
control to stimulation procedures.
Statistical analysis
Subjects were divided into two groups according to
systolic and diastolic blood pressure–systolic blood
pressure (<120 and >120 mmHg) and diastolic blood
pressure (<80 and >80 mmHg). Differences in
measured variables and CD11b/CD18 expression were
analysed using the nonparametric Mann–Whitney U
test (Table 1) for non-normally distributed data with
variables expressed as median and 10th and 90th
percentiles. Comparisons for the systolic blood
pressure categories for age, systolic and diastolic
blood pressure and body mass index (BMI) were
made with Student’s t test with results expressed as
mean and standard deviation. Regression analysis was
used to assess any association between blood pressure




Table 1 shows the characteristics for measured
variables for the 20 male and 18 female subjects with
mean age 85 years and grouped according to systolic
blood pressure <120 and >120 mmHg. There were no
significant differences in total cholesterol, LDL or
HDL fractions for subjects with systolic blood
pressure >120 mmHg compared to those with
blood pressure <120 mmHg, although BMI was
higher is the >120 mmHg group. No subject was
diabetic.
Smoking and medication
Only four subjects were smokers (Table 1) with
comparable percentages for each blood pressure
category—one subject in the <120 mmHg (12.5%)
and three subjects in the >120-mmHg blood pressure
groups (10%). Subject use of aspirin and antihyper-
tensive agent/s is also documented in Table 1. The
most commonly prescribed antihypertensive medica-
tion was a single agent from the diuretic-related
antihypertensive class of drugs, with two subjects in
the <120 mmHg and five subjects in the >120-mmHg
systolic blood pressure groups using this type of
medication. One subject in each blood pressure group
used a β-blocker. Two subjects in the >120-mmHg
blood pressure group used an angiotensin-converting
enzyme (ACE) drug—captopril or lisinopril. An
antihypertensive drug from the calcium channel
blocker group was used as a single agent by three
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other subjects in the >120-mmHg blood pressure
group. Three subjects in this group used a combina-
tion of more than one antihypertensive agent. No
subject in the <120-mmHg blood pressure group used
aspirin, whereas four subjects in the >120-mmHg
blood pressure group used this preparation, usually in
a dose of 300 mg, as was more common at the time of
recruitment.
Effect of TNF-α 10 and 100 IU
Flow cytometry results are expressed as MCF with
box and whisker plots (Fig. 1). Expression of CD11b
on the surface of neutrophils, monocytes and lym-
phocytes increased from baseline in a dose-dependent
manner after stimulation with 10 and 100 IU amounts
of TNF-α, respectively. Neutrophils and monocytes
demonstrated more CD11b expression (approximately
10-fold) compared to lymphocytes (Fig. 1) both at
baseline and with 10 and 100 IU of TNF-α.
Association with blood pressure
Figure 2 shows the regression line and association
between increased CD11b expression on neutrophils
(R2=0.12, p=0.04) and monocytes (R2=0.11, p=
0.05) and increasing systolic blood pressure. Subjects,
categorised by systolic blood pressure >120 and
<120 mmHg, showed significantly higher baseline
and 10 IU TNF-α stimulated CD11b expression on
both neutrophils and monocytes (p<0.05), though this
effect became attenuated at the 100 IU concentration
of TNF-α (Fig 1). Similarly, lymphocytes showed
significantly higher CD11b baseline up-regulation for






Subject number 8 30
Sex 4 [M], 4 [F] 16 [M], 14 [F]
Systolic blood pressure 118.8 [3.5] 143.7 [11.1] <0.001*
Diastolic blood pressure 78.7 [8.3] 89.0 [6.3] 0.003*
Age (years) 87.6 [5.1] 83.2 [6.9] 0.04*
Cholesterol (mg/dl) 188.7 (170, 216.2) 213.5 (139, 246.3) 0.23
LDL cholesterol (mg/dl) 125.1 (96.9, 145.9) 147.5 (89.6, 174.5) 0.48
HDL cholesterol (mg/dl) 31.0 (24.2, 59.8) 40.9 (30.4, 60.2) 0.18
Urea nitrogen (mg/dl) 17.2 (12.4, 23.6) 18.2 (11.6, 31.1) 0.50
Glucose (mg/dl) 79.3 (74.4, 107.4) 82.9 (72.1, 100.2) 0.67
BMI 22.5 [1.64] 25.9 [4.1] 0.02*
Smoking 1 [12.5%] 3 [10%]
Hypertensive drugs
Diuretic related 2 5
β-blockers 1 1
ACE 0 2
Calcium CB 0 3
Combinations 0 3
Aspirin 0 4
Mean and standard deviation are indicated in square brackets, p values by t test. Median and 10th and 90th percentiles in parenthesis,
p values by Mann–Whitney U. To convert values of urea nitrogen to millimoles per litre multiply by 0.357. To convert values of
glucose to millimoles per litre multiply by 0.0555. To convert values of cholesterol, LDL and HDL to millimoles per litre multiply by
0.259
M male, F female, BMI body mass index, ACE ACE inhibitor, Calcium CB calcium channel blocker, Combinations >1 hypertensive
drug
*p<0.05 significant
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subjects with systolic blood pressure >120 mmHg
compared with <120 mmHg, although no increased
effect was seen with TNF-α. Diastolic blood pressure
>80 mmHg was associated with a modest but
significant up-regulation of baseline and TNF-α
stimulated CD11b expression on lymphocytes alone
(Fig. 3). No changes were seen for any increase in
diastolic blood pressure for neutrophils or monocytes.
Discussion
The most important finding in this study in elderly
BELFAST subjects was the apparent association
between up-regulation of the β2 integrin adhesion
molecule CD11b on neutrophils, monocytes and
lymphocytes in subjects who also had systolic blood
pressure greater than 120 mmHg. This fits with the
putative suggestion that hypertension may induce a
pro-inflammatory response in the endothelium
induced by mechanical stretching or pulse pressure
changes (Krieglstein and Granger 2001; Katsumi et
al. 2004) and is consistent with ‘in vitro’ work
showing that stretching of endothelial cells stimulates
cytokine release (Cheng et al. 1996).
There is a large body of accumulating evidence
from epidemiological studies and meta-analyses,
Fig. 3 Mean channel fluorescence CD11b for lymphocytes
categorised by diastolic blood pressure <80 and >80 mmHg
showing box and whisker plots for median and 25th and 75th
percentiles
Fig. 2 Regression line and association between increasing
systolic blood pressure and mean channel fluorescence CD11b
for neutrophils and monocytes with R2 values
Fig. 1 Mean channel fluorescence CD11b for neutrophils,
monocytes and lymphocytes categorised by systolic blood
pressure <120 and >120 mmHg showing box and whisker
plots for median and 25th and 75th percentiles
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showing that systolic hypertension has a strong,
consistent and graded influence on mortality and
morbidity from cardiovascular disease, stroke and
end-stage renal disease. For each 20 mmHg increase
in systolic blood pressure and 10 mmHg increase in
diastolic pressure greater than 115/75 mmHg, there
was a twofold increase in mortality associated with
stroke and cardiovascular disease (Lewington et al.
2002). Although arguments continue about the blood
pressure category ‘prehypertension’ (Chobanian et al.
2003), subsequent studies, including the recent meta-
analysis by Thompson et al. (2011), show clear
evidence that increases in blood pressure above 120/
80 mmHg (prehypertension range) are associated with
continuous, graded and independent increased risk of
atherosclerotic-related events (Lewington et al. 2002).
Contrary to original opinion, the association of
systolic blood pressure with cardiovascular and renal
disease is much stronger than the corresponding
relationship for diastolic blood pressure. In this
context, it is of interest that in the current study, only
lymphocytes showed an increase in baseline CD11b
expression with diastolic blood pressure above
80 mmHg, whereas all three cell types showed an
increased response for systolic blood pressure above
120 mmHg. For the BELFAST subjects in this study
of mean age 85 years, increased adhesion molecule
up-regulation occurred with blood pressures within
and above the range of blood pressure of 120/
80 mmHg.
One other related finding is that CD11b up-
regulation was accentuated on neutrophils and mono-
cytes by prior ‘in vitro’ stimulation with TNF-α, a
cytokine which stands at the centre of the inflamma-
tory response. TNF-α is produced early in inflamma-
tion from a wide range of cells but mainly from
monocytes and is up-regulated in both acute illnesses
such as chest infection, and a whole range of chronic
inflammatory diseases such as rheumatoid arthritis. In
the present study, prior stimulation of neutrophils and
monocytes with 10 and 100 IU of TNF-α produced
large increases from baseline CD11b expression (100-
fold for monocytes), which were further increased
(approximately by 25%), in subjects with systolic
blood pressure >120 mmHg. Others have noted pre-
activation of monocytes in subjects with hypertension
with accompanying cytokine changes (Dorffel et al.
1999; Dalekos et al. 1997). The current finding seems
likely to have important implications for clinical
situations. It suggests that acute or chronic inflamma-
tion capable of increasing TNF-α could greatly
increase adhesion molecule up-regulation in subjects
with even moderately increased systolic blood pres-
sure. The augmented pro-inflammatory milieu could
lead to increased vascular risk associated with
inflammation. It is already recognised that management
of chronic diseases such rheumatoid arthritis which
carry an increased vascular risk can be ameliorated by
use of various anti-TNF-α direct and indirect monoclonal
antibodies (Jacobsson et al. 2005).
This study has a number of limitations. Blood
pressure was measured only once using a conventional
mercury sphygmomanometer and Korotkoff sounds,
with each subject resting for 10 min prior to measure-
ment. With respect to a single blood pressure measure-
ment using the Korotkoff method, evidence from
Lewington et al. (2002) of nearly one million people
in 61 studies showed remarkably similar blood
pressure measurements for seated subjects, when
using either a standard or random zero sphygmoma-
nometer, with Korotkoff sounds used to define
systolic and diastolic phases. This study further noted
that if ‘[a] single measurement of blood pressure
[was] used to predict risk then, irrespective of age,
systolic blood pressure was more informative than
diastolic pressure’. Staessen et al. (1999) too advised
that the Riva Rocci/Korotkoff technique, although
prone to error, was easy and cheap to perform and
remained worldwide, the standard procedure for
measuring blood pressure. Our choice of 10 min rest
was both pragmatic—in order not to tire elderly subjects
and return samples promptly for processing—and
evidence-based, as Sala et al. (2006) demonstrated, on
the basis of their repeated measurement of blood
pressure at clinic, that 75% of the spontaneous fall
occurred within 10 min. They suggested that 10 min
rest before blood pressure measurement at clinic
could improve precision and accuracy. Our subjects
were seen in the familiar environment of their own
home, and this fits with evidence showing that
home measurement provides better sensitivity for
ruling out hypertension, compared to clinic mea-
surement (Hodgkinson et al. 2011).
The numbers of older subjects involved in this
study could have reduced the overall statistical power.
Recruitment was slow because subjects were elderly
with a mean age of 85 years, were community living
and relatively few could meet both the ‘elite’ criteria
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of the BELFAST (Rea et al. 1997, 2009) and the
exacting demands of the Senieur protocol for
immune-gerontological studies (Ligthart et al. 1984).
The subject group enrolled from within the ongoing
BELFAST study was also subject to time constraints
imposed by the completion of a master’s research
project (Armstrong et al. 2001). Findings, therefore,
need to be replicated by other groups. Research
studies at this age remain scarce but give valuable
insights into factors related to the demographic
change evident around us. However they are chal-
lenging because of subject frailty, real or perceived
vulnerability and lack of family understanding about
autonomy of research participants (Samuelson et al.
2008). These factors contributed importantly to
recruitment success and time delays.
Hypertension is a silent disease with poor compli-
ance (Knight et al. 2000). The oldest age group has
both the highest incidence of hypertension and risk of
vascular events including stroke (Hyman and Pavlik
2001; Lewington et al. 2002; Kannel et al. 2008;
Clarke et al. 2002; Cooperative Research Group
1991). Understanding how hypertension produces
vascular damage and drives cellular adhesion is
important since it can help direct doctor and patient
treatment strategies and improve compliance. There is
increasing evidence that adhesion molecules can be
blocked or down-regulated by a range of pharmaco-
logical and nonpharmacological mechanisms. The
work of Link et al. (2006) found that CD11b
expression was inhibited by angiotensin 11 receptor
blockers and suggested that this effect was mediated
by blockage of the probable paracrine, autocrine and
intracine pro-inflammatory vascular mechanisms,
driven by the renin–angiotensin system. Additionally,
aspirin often used in hypertension because of its anti-
platelet effect has been shown to reduce monocyte
adhesion by inhibiting the NF-κB pro-inflammatory
pathway (Weber et al. 1995; Eisele et al. 2004). There
is also recent evidence from animal models that
aspirin acts synergistically with angiotensin 11 recep-
tor blockers to protect the vasculature from angioten-
sin 11-induced organ damage (Muller et al. 2001;
Mulay et al. 2010). Nonpharmacological substances
such as vitamin C also suppresses TNF-α-induced
NF-κB-activated expression by an antioxidant-related
mechanism (Carcamo et al. 2002) and resveratrol,
from red wine, blunts TNF-α-induced monocyte
adhesion (Kim et al. 2007). In this context it is of
interest that the Thompson meta-analysis (Thompson
et al. 2011), demonstrated in 63,259 participants, who
received either an angiotensin-converting enzyme in-
hibitor, an angiotensin receptor blocker or combination
antihypertensive therapy including an angiotensin-
converting enzyme drug that there was a significant
reduction in risk of stroke, congestive heart failure,
cardiovascular events and all cause mortality compared
with those not receiving angiotensin-converting
enzyme-related antihypertensive therapy, even when
blood pressure was not in the hypertensive range. The
authors note that their ‘meta-analysis was not a
mechanistic study and could not therefore determine
whether the benefit associated with the use of antihy-
pertensive treatment was attributable to blood pressure
lowering or to other tissue or neurohormonal mecha-
nisms’. However it could be argued that reducing
cellular adhesion could have been a contributory factor
to the improved outcomes. Importantly, in the present
study, aspirin and/or ACE inhibitor use was confined to
subjects in the >120-mmHg blood pressure group,
where they could have potentially attenuated CD11b
expression.
This study, in older subjects, suggests an associa-
tion between increases in blood pressure and in-
creased adhesion on leucocytes. Stickiness was
further enhanced by TNF-α prestimulation, a situation
likely clinically in association with any acute or
chronic inflammation. Populations of octogenarians
and nonagenarians are the fastest growing sector of
western populations, and their vasculature is at risk.
Stroke, the most tragic consequence of untreated
hypertension (Kannel et al. 2008), increases with
age and robs people of their autonomy. These findings
support calls for better control of blood pressure and
to a lower level (Beckett et al. 2008; Meissner et al.
1999), irrespective of age. Perhaps then better quality
ageing and the ‘longevity dividend’ can become a
reality for everyone (Butler et al. 2008; Bennati et al.
2010).
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